(secondQuint)Study of Itraconazole in Patients With Advanced HIV Infection.

 Patients will receive intravenous itraconazole solution twice daily for 2 days and then once daily for five additional days.

 Patients then randomized to receive twice-daily or once-daily itraconazole oral solution for an additional 28 days.

.

 Study of Itraconazole in Patients With Advanced HIV Infection@highlight

To demonstrate a dosage regimen for intravenous itraconazole that produces a plasma concentration range comparable to that obtained after currently used oral dosages of itraconazole oral solution; and to obtain preliminary safety data in patients with advanced HIV disease.

